Prolactinoma and systemic lupus erythematosus: Do serum prolactin levels matter?

Clinical Rheumatology

Volumn 25, Issue 4, 2006, Pages 602-605

  Li, Margaret ^a   Keiser, Harold D ^a   Peeva, Elena ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Hyperprolactinemia; Prolactin; Prolactinoma; Systemic lupus erythematosus

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; BROMOCRIPTINE; CABERGOLINE; CALCIUM; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DOUBLE STRANDED DNA ANTIBODY; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NAPROXEN; PREDNISONE; PROLACTIN; THYROTROPIN; THYROXINE; VITAMIN D; WARFARIN;

ACUTE PANCREATITIS; ADULT; ALLERGIC REACTION; AMENORRHEA; ARTERY OCCLUSION; ARTHRITIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPLEMENT BLOOD LEVEL; CONTRAST ENHANCEMENT; CUSHINGOID SYNDROME; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; FATIGUE; FEMALE; FEVER; FOLLOW UP; GALACTORRHEA; GENETIC DIFFERENCE; HEADACHE; HEMIANOPIA; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; IMMUNOASSAY; INTERNAL CAROTID ARTERY; LUNG EMBOLISM; MAGNETIC RESONANCE ANGIOGRAPHY; MOUTH ULCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOSENSITIVITY; PLEURA EFFUSION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; PROTEINURIA; RASH; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX PAIN; THROMBOCYTE COUNT; THROMBOPHLEBITIS; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; CHILD; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA;

EID: 33746496099     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-005-0117-x     Document Type: Article

References (14)

1. Schlechte J (2003) Prolactinoma. N Engl J Med 349:2035-2041
2. Peeva E, Venkatesh J, Michael D, Diamond B (2004) Prolactin as a modulator of B cell function; implications for SLE. Biomed Pharmacother 58:310-319
3. Lahita R (1999) The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 11:352-356
4. Funauchi M, Ikoma S, Enomoto H, Sugiyama M, Ohno M, Hamada K, Kanamaru A (1998) Prolactin modulates the disease activity of systemic lupus erythematosus accompanied by prolactinoma. Clin Exp Rheumatol 16:479-482
5. McMurray R, Allen SH, Braun AL, Rodriguez F, Walker SE (1994) Longstanding hyperprolactinemia associated with systemic lupus erythematosus: Possible hormonal stimulation of an autoimmune disease. J Rheumatol 21:843-850
6. Reuman P (2004) First reported pediatric case of systemic lupus erythematosus associated with prolactinoma. Arthritis Rheum 50:3616-3618
7. Chikanza I (1999) Prolactin and neuroimmunomodulation: In vitro and in vivo observations. Ann N Y Acad Sci 876:119-130
8. McMurray R et al (1991) Prolactin influences autoimmune disease activity in the female NZB/W mouse. J Immunol 147:3780-3787
9. McMurray R, Keisler D, Izui S, Walker S (1994) Hyperprolactinemia in male NZB/NZW (B/W) F1 mice: Accelerated autoimmune disease with normal circulating testosterone. Clin Immunol Immunopathol 71:338-343
10. Peeva E, Michael D, Cleary J, Rice J, Chen X, Diamond B (2003) Prolactin modulates the naive B cell repertoire. J Clin Invest 111:275-283
11. Kanda N, Tsuchida T, Tamaki K (1999) Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 42:328-337
12. McMurray R et al (1995) Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. J Rheumatol 22:2084-2091
13. Guitelman M, Colombani-Vidal ME, Zylbersztein CC, Fiszlejder L, Zeller M, Levalle O, Scaglia HE (2002) Hyperprolactinemia in asymptomatic patients is related to high molecular weight posttranslational variants or glycosylated forms. Pituitary 5:255-260
14. Leanos-Miranda A, Chavez-Rueda K, Blanco-Favela F (2001) Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus. Arthritis Rheum 44:866-875